Login / Signup

An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective.

Yoshifumi Saisho
Published in: Expert opinion on pharmacotherapy (2020)
Management of T2DM including lifestyle modification as well as pharmacotherapy should be focused on reducing beta cell workload, to preserve functional beta cell mass. A paradigm shift from a glucose-centric to a beta cell-centric concept of T2DM enhances the implementation of person-centered diabetes care.
Keyphrases
  • type diabetes
  • single cell
  • cell therapy
  • cardiovascular disease
  • glycemic control
  • healthcare
  • stem cells
  • primary care
  • physical activity
  • blood glucose
  • mesenchymal stem cells
  • insulin resistance